<DOC>
	<DOCNO>NCT00251134</DOCNO>
	<brief_summary>Cardiovascular disease ( CVD ) lead cause death North America Europe . The major cause CVD atherosclerosis like coronary artery disease ( CAD ) . The result recent trial hint course CAD may positively influence increased intake omega 3-fatty acid . The OMEGA-Trial analysis effect subject suffer acute myocardial infarction . They divide two group , receive standard post-infarction therapy . The subject one group additionally receive 1 gram omega 3-fatty acid daily time-period 12 month , subject second group receive 1 gram olive-oil placebo . Within period 12 month event report used analyse efficacy safety additional therapy omega 3-fatty acid .</brief_summary>
	<brief_title>OMEGA-Study : Effect Omega 3-Fatty Acids Reduction Sudden Cardiac Death After Myocardial Infarction</brief_title>
	<detailed_description />
	<mesh_term>Infarction</mesh_term>
	<mesh_term>Myocardial Infarction</mesh_term>
	<mesh_term>Death</mesh_term>
	<mesh_term>Death , Sudden , Cardiac</mesh_term>
	<criteria>Myocardial infarction 314 day randomisation ( STEMI NSTEMI ) Ability take Î©3FAE olive oil without risk Informed consent Premenopausal woman surgically sterile , pregnant nursing , childbearing potential practising acceptable mean birth control ( pregnancy testing require randomisation ) Known hypersensitivity study medication Dislike fish oil Haemorrhagic diathesis Unwillingness discontinue medication contain fish oil Legal incapacity History drug alcohol abuse within 6 month Any investigational therapy within one month signing informed consent form</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2008</verification_date>
	<keyword>myocardial infarction</keyword>
	<keyword>omega 3-fatty acid</keyword>
</DOC>